{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T22:47:18Z","timestamp":1769122038269,"version":"3.49.0"},"reference-count":21,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2004,9,23]],"date-time":"2004-09-23T00:00:00Z","timestamp":1095897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J American Geriatrics Society"],"published-print":{"date-parts":[[2004,10]]},"abstract":"<jats:p>\n                    <jats:bold>Objectives:<\/jats:bold>\n                    To compare the risk of congestive heart failure (CHF) in elderly individuals treated with any peripheral alpha\u20101 antagonist for hypertension with any thiazide, test whether the risk persists in subjects without cardiovascular disease (CVD) at baseline, and examine CHF risk in normotensive men with prostatism treated with alpha antagonists.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Design:<\/jats:bold>\n                    Prospective cohort study.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Setting:<\/jats:bold>\n                    Four U.S. sites: Washington County, Maryland; Allegheny County, Pennsylvania; Sacramento County, California; and Forsyth County, North Carolina.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Participants:<\/jats:bold>\n                    A total of 5,888 community\u2010dwelling subjects aged 65 and older.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Measurements:<\/jats:bold>\n                    Adjudicated incident CHF.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    The 3,105 participants with treated hypertension were at risk for CHF; 22% of men and 8% of women took alpha antagonists during follow\u2010up. The age\u2010adjusted risk of CHF in those receiving monotherapy treated with alpha antagonists was 1.90 (95% confidence interval=1.03\u20133.50) compared with thiazides. In subjects without CVD at baseline receiving monotherapy, women taking an alpha antagonist had a 3.6 times greater age\u2010adjusted risk of CHF, whereas men had no difference in risk. Adjustment for systolic blood pressure attenuated statistical differences in risk. There were 930 men without hypertension at risk for CHF; 5% used alpha antagonists during follow\u2010up, with no observed increase in CHF risk.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    Subjects receiving alpha antagonist monotherapy for hypertension had a two to three times greater risk of incident CHF, also seen in lower\u2010risk subjects, but differences in blood pressure control partly explained this.\n                  <\/jats:p>","DOI":"10.1111\/j.1532-5415.2004.52456.x","type":"journal-article","created":{"date-parts":[[2004,9,23]],"date-time":"2004-09-23T05:21:19Z","timestamp":1095916879000},"page":"1648-1654","source":"Crossref","is-referenced-by-count":10,"title":["Risk of Congestive Heart Failure in an Elderly Population Treated with Peripheral Alpha\u20101 Antagonists"],"prefix":"10.1111","volume":"52","author":[{"given":"Chris L.","family":"Bryson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lewis H.","family":"Kuller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo H. M.","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teri A.","family":"Manolio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward J.","family":"Boyko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curt D.","family":"Furberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce M.","family":"Psaty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,9,23]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"739","article-title":"Health outcomes associated with antihypertensive therapies used as first\u2010line agents","volume":"277","author":"Psaty BM","year":"1997","journal-title":"A systematic review and meta-analysis"},{"key":"e_1_2_7_3_2","first-page":"212","article-title":"Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension","volume":"278","author":"Kostis JB","year":"1997","journal-title":"SHEP Cooperative Research Group"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.1967"},{"key":"e_1_2_7_5_2","first-page":"2325","article-title":"Time trends in high blood pressure control and the use of antihypertensive medications in older adults","volume":"162","author":"Psaty BM","year":"2002","journal-title":"The Cardiovascular Health Study"},{"key":"e_1_2_7_6_2","first-page":"263","article-title":"The Cardiovascular Health Study","volume":"1","author":"Fried LP","year":"1991","journal-title":"Design and rationale"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/1047-2797(94)00092-8"},{"key":"e_1_2_7_8_2","first-page":"63","article-title":"Echocardiographic design of a multicenter investigation of free\u2010living elderly subjects","volume":"5","author":"Gardin JM","year":"1992","journal-title":"The Cardiovascular Health Study"},{"key":"e_1_2_7_9_2","first-page":"683","article-title":"Assessing the use of medications in the elderly","volume":"45","author":"Psaty BM","year":"1992","journal-title":"Methods and initial experience in the Cardiovascular Health Study. The Cardiovascular Health Study Collaborative Research Group"},{"key":"e_1_2_7_10_2","first-page":"278","article-title":"Surveillance and ascertainment of cardiovascular events","volume":"5","author":"Ives DG","year":"1995","journal-title":"The Cardiovascular Health Study"},{"key":"e_1_2_7_11_2","first-page":"1948","article-title":"Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction","volume":"33","author":"Vasan RS","year":"1999","journal-title":"Prevalence and mortality in a population-based cohort"},{"key":"e_1_2_7_12_2","first-page":"313","article-title":"Relationship of antihypertensive treatment regimens and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or chlorthalidone","volume":"137","author":"Davis BR","year":"2002","journal-title":"Further analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1056-8727(00)00071-4"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199805000-00005"},{"key":"e_1_2_7_15_2","first-page":"1549","article-title":"Long\u2010term effects on plasma lipids of diet and drugs to treat hypertension","volume":"275","author":"Grimm RH","year":"1996","journal-title":"Treatment of Mild Hypertension Study (TOMHS) Research Group"},{"key":"e_1_2_7_16_2","first-page":"575","article-title":"Comparative trial of doxazosin and atenolol on cardiovascular risk reduction in systemic hypertension","volume":"71","author":"Carruthers G","year":"1993","journal-title":"The Alpha Beta Canada Trial Group"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/1468-6708-3-7"},{"key":"e_1_2_7_18_2","first-page":"285","article-title":"Reduced heat shock proteins","volume":"15","author":"Hooper PL.","year":"2001","journal-title":"A mechanism to explain higher cardiovascular events associated with doxazosin"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(02)02307-X"},{"key":"e_1_2_7_20_2","first-page":"914","article-title":"Single\u2010drug therapy for hypertension in men","volume":"328","author":"Materson BJ.","year":"1993","journal-title":"A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200101043440103"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-12-200112180-00011"}],"container-title":["Journal of the American Geriatrics Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1532-5415.2004.52456.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1532-5415.2004.52456.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T11:59:33Z","timestamp":1762171173000},"score":1,"resource":{"primary":{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1532-5415.2004.52456.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,23]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["10.1111\/j.1532-5415.2004.52456.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1532-5415.2004.52456.x","archive":["Portico"],"relation":{},"ISSN":["0002-8614","1532-5415"],"issn-type":[{"value":"0002-8614","type":"print"},{"value":"1532-5415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,23]]}}}